New mathematical model for examination of cervical cancer by using diffusion–weighted magnetic resonance imaging

Vaida Atstupenaite1 , Algidas Basevicius2 , Saulius Lukosevicius3 , Vincentas Veikutis4 , Daiva Vaitkiene5 , Arturas Inciura6 , Vidmantas Januskevicius7 , Dinas Vaitkaitis8

1, 2, 3Lithuanian University of Health Sciences, Medical Academy, Dept. of Radiology, Lithuania

4Lithuanian University of Health Sciences, Institute of Cardiology, Lithuania

5Lithuanian University of Health Sciences, Medical Academy, Dept. of Obstetrics and Gynaecology, Lithuania

6Lithuanian University of Health Sciences, Institute of Oncology, Lithuania

7Lithuanian University of Health Sciences, Dept. of Environmental and Occupational Medicine, Lithuania

8Lithuanian University of Health Sciences, Dept. of Disaster Medicine, Lithuania

Journal of Vibroengineering, Vol. 15, Issue 2, 2013, p. 675-683.
Received 5 November 2012; accepted 3 June 2013; published 30 June 2013

Copyright © 2013 Vibroengineering This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons License
Table of Contents Full-text Download PDF References
Cite this article
Views 29
Reads 9
Downloads 1475

We compare the mean value of apparent diffusion coefficient (ADC) in a healthy cervix, cancer affected cervix and the cervix after chemoradiation therapy and evaluate the correlation of the value of ADC with the various clinical and histological findings. Prospective clinical study accomplished in Lithuanian University of Health Sciences University Clinical Hospital. Magnetic resonance imaging (MRI) examinations performed on 117 women with and 49 women without cervical cancer by using a 1.5 Tesla scanner. Diffusion–weighted (DW) imaging was performing by using b values of 50, 400 and 800 s/mm2. ADC measured in a healthy cervix, cancer affected cervix and the cervix 6 months after chemoradiation therapy. The mean ADC of the patients of the study group – 0.658±0.120×10-3 mm2/s was considerably lower than the mean of the control group – 1.169±0.134×10-3 mm2/s (t= 24.123, p= 0.02). There was no correlation between mean ADC and the stage of the disease, the histological type or grade of the tumor. A weak negative correlation was detected between ADC and the age of the subjects (r= –0,337, p= 0,000). The mean ADC of responders increased to 1.111±0.138×10-3 mm2/s, the mean ADC of non-responders remained lower – 0.733±0.073×10-3 mm2/s (t= 9.158, p= 0.04). The ADC value in the case of cervical cancer is significantly lower than in the non-affected cervical tissue. It increases after effective chemoradiation therapy and becomes closer to the coefficient value of non-affected cervical tissue but remains lower. We cannot credibly consider about the stage of the disease, the histological type and grade of the tumor, according to the ADC value of cervical cancer. Slight decreasing of ADC value closely relate with elderly of patients.

Keywords: MRI, diffusion–weighted MRI, apparent diffusion coefficient, cervical cancer, chemoradiation therapy, mathematical model.


  1. Arbyn M., Antoine J., Valerianova Z., Mägi M., Stengrevics A., Smailyte G. et al. Trends in cervical cancer incidence and mortality in Bulgaria, Estonia, Latvia, Lithuania and Romania. Tumori., 2010, Vol. 96, p. 517-523. [Search CrossRef]
  2. Schiffman M., Castle P., Jeronimo J., Rodriguez A., Wacholder S. Human papillomavirus and cervical cancer. Lancet., 2007, Vol. 370, No. 9590, p. 890-907. [Search CrossRef]
  3. Moore D. H. Cervical cancer. Obstet. Gynecol., 2006, Vol. 107, Issue 5, p. 1152-1161. [Search CrossRef]
  4. Kinkel K. Pitfalls in staging uterine neoplasm with imaging: a review. Abdom. Imaging, 2006, Vol. 31, Issue 2, p. 164-173. [Search CrossRef]
  5. Balleyguier C., Sala E., Da Cunha T., Bergman A., Brkljacic B., Danza F. et al. Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital Radiology. Eur. Radiol., 2011, Vol. 21, Issue 5, p. 1102-1110. [Search CrossRef]
  6. Harry V. N., Deans H., Ramage E., Parkin D. E., Gilbert F. J. Magnetic resonance imaging in gynecological oncology. Int. J. Gynecol. Cancer, 2009, Vol. 19, Issue 2, p. 186-193. [Search CrossRef]
  7. Padhani A. R., Khan A. A. Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy. Targ. Oncol., 2010, Vol. 5, p. 39-52. [Search CrossRef]
  8. Whittaker C. S., Coady A., Culver L., Rustin G., Padwick M., Padhani A. R. Diffusion-weighted MR imaging of female pelvic tumors: a pictorial review. Radiographics, 2009, Vol. 29, Issue 3, p. 759-778. [Search CrossRef]
  9. Koh D. M., Thoeny H. C. Diffusion-Weighted MR Imaging. Berlin, Springer, 2010. [Search CrossRef]
  10. Koh D. M., Collins D. J. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am. J. Roentgenol., 2007, Vol. 188, p. 1622-1635. [Search CrossRef]
  11. Punwani S. Diffusion weighted imaging of female pelvic cancers: concepts and clinical applications. Eur. J. Radiol., 2011, Vol. 78, Issue 1, p. 21-29. [Search CrossRef]
  12. Thoeny H. C., Ross B. D. Predicting and monitoring cancer treatment response with diffusion-weighted MRI. J. Magn. Reson. Imaging, 2010, Vol. 32, Issue 1, p. 2-16. [Search CrossRef]
  13. Naganawa S., Sato C., Kumada H., Ishigaki T., Miura S., Takizawa O. Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix. Eur. Radiol., 2005, Vol. 15, p. 71-78. [Search CrossRef]
  14. Zhang Y., Liang B. L., Gao L., Ye R. X., Shen J., Zhong J. L. Diffusion weighted imaging features of normal uterine cervix and cervical carcinoma. Ai. Zheng., 2007, Vol. 26, Issue 5, p. 508-512, (in Chinese). [Search CrossRef]
  15. McVeigh P. Z., Syed A. M., Milosevic M., Fyles A., Haider M. A. Diffusion-weighted MRI in cervical cancer. Eur. Radiol., 2008, Vol. 18, p. 1058-1064. [Search CrossRef]
  16. Xue H. D., Li S., Sun F., Sun H. Y., Jin Z. Y., Yang J. X. et al. Clinical application of body diffusion weighted MR imaging in the diagnosis and preoperative N staging of cervical cancer. Chin. Med. Sci. J., 2008, Vol. 23, Issue 3, p. 133-137. [Search CrossRef]
  17. Charles-Edwards E. M., Messiou C., Morgan V. A., De Silva S. S., McWhinney N. A., Katesmark M. et al. Diffusion-weighted imaging in cervical cancer with an endovaginal technique: potential value for improving tumor detection in stage Ia and Ib1 disease. Radiology, 2008, Vol. 249, Issue 2, p. 541-550. [Search CrossRef]
  18. Liu Y., Bai R., Sun H., Liu H., Wang D. Diffusion-weighted magnetic resonance imaging of uterine cervical cancer. J. Comput. Assist. Tomogr., 2009, Vol. 33, Issue 6, p. 858-862. [Search CrossRef]
  19. Chen Y. B., Hu C. M., Chen G. L., Hu D., Liao J. Staging of uterine cervical carcinoma: whole-body diffusion-weighted magnetic resonance imaging. Abdom. Imaging, 2010. [Search CrossRef]
  20. Chen J., Zhang Y., Liang B., Yang Z. The utility of diffusion-weighted MR imaging in cervical cancer. Eur. J. Radiol., 2010, Vol. 74, Issue 3, p. 101-106. [Search CrossRef]
  21. Payne G. S., Schmidt M., Morgan V. A., Giles S., Bridges J., Ind T. et al. Evaluation of magnetic resonance diffusion and spectroscopy measurements as predictive biomarkers in stage 1 cervical cancer. Gynecol. Oncol., 2010, Vol. 116, Issue 2, p. 246-252. [Search CrossRef]
  22. Rizzo S., Summers P., Raimondi S., Belmonte M., Maniglio M., Landoni F. et al. Diffusion-weighted MR imaging in assessing cervical tumour response to nonsurgical therapy. Radiol. Med., 2011, Vol. 116, Issue 5, p. 766-780. [Search CrossRef]
  23. Hoogendam J. P., Klerkx W. M., De Kort G. A., Bipat S., Zweemer R. P., Sie-Go D. M. et al. The influence of the b-value combination on apparent diffusion coefficient based differentiation between malignant and benign tissue in cervical cancer. J. Magn. Reson. Imaging, 2010, Vol. 32, Issue 2, p. 376-382. [Search CrossRef]
  24. Harry V. N., Semple S. I., Gilbert F. I., Parkin D. E. Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. Gynecol. Oncol., 2008, Vol. 111, p. 213-220. [Search CrossRef]
  25. Liu Y., Bai R., Sun H., Liu H., Zhao X., Li Y. Diffusion-weighted imaging in predicting and monitoring the response of uterine cervical cancer to combined chemoradiation. Clin. Radiol., 2009, Vol. 64, Issue 11, p. 1067-1074. [Search CrossRef]
JVE Journals is rebranding to Extrica

Inspired by innovations from the previous century and the rapid growth during the last years, we are improving for excellence in your publishing experience

Read to know more
JVE Journals